US Stock Market Move | The United States government has received a $590 million grant for the development of avian influenza vaccines, causing Moderna (MRNA.US) to rise more than 6%.

On Tuesday, Moderna (MRNA.US) opened up over 6%, trading at $36.30. In terms of news, the US government has granted Moderna $590 million to advance its research and development of a bird flu vaccine. This funding is in addition to the $176 million granted by the US Department of Health and Human Services (HHS) last year, which was used to complete late-stage development and testing of an mRNA-based H5N1 bird flu pandemic vaccine.